Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 682 entries
Sorted by: Best Match Show Resources per page
Isolation of lipoprotein A with hydrated density characteristic for low density lipoproteins.

FEBS letters

Kostner G.
PMID: 11946373
FEBS Lett. 1972 Jan 15;20(1):25-28. doi: 10.1016/0014-5793(72)80008-5.

No abstract available.

Cite
Kostner G. Isolation of lipoprotein A with hydrated density characteristic for low density lipoproteins. FEBS Lett. 1972;20(1):25-28doi: 10.1016/0014-5793(72)80008-5.
Kostner, G. (1972). Isolation of lipoprotein A with hydrated density characteristic for low density lipoproteins. FEBS letters, 20(1), 25-28. https://doi.org/10.1016/0014-5793(72)80008-5
Kostner, G. "Isolation of lipoprotein A with hydrated density characteristic for low density lipoproteins." FEBS letters vol. 20,1 (1972): 25-28. doi: https://doi.org/10.1016/0014-5793(72)80008-5
Kostner G. Isolation of lipoprotein A with hydrated density characteristic for low density lipoproteins. FEBS Lett. 1972 Jan 15;20(1):25-28. doi: 10.1016/0014-5793(72)80008-5. PMID: 11946373.
Copy Download .nbib Format: NLM
Hypercholesterolemia and Dyslipidemia.

Current treatment options in cardiovascular medicine

Superko HR.
PMID: 11096522
Curr Treat Options Cardiovasc Med. 2000 Apr;2(2):173-187. doi: 10.1007/s11936-000-0010-5.

Disorders of cholesterol and lipoprotein metabolism are at the heart of atherosclerosis and coronary artery disease (CAD). CAD, however, is a metabolic disorder that involves a complex interaction between genetic susceptibility and environmental conditions. Despite considerable success in the...

Cite
Superko HR. Hypercholesterolemia and Dyslipidemia. Curr Treat Options Cardiovasc Med. 2000;2(2):173-187doi: 10.1007/s11936-000-0010-5.
Superko, H. R. (2000). Hypercholesterolemia and Dyslipidemia. Current treatment options in cardiovascular medicine, 2(2), 173-187. https://doi.org/10.1007/s11936-000-0010-5
Superko. "Hypercholesterolemia and Dyslipidemia." Current treatment options in cardiovascular medicine vol. 2,2 (2000): 173-187. doi: https://doi.org/10.1007/s11936-000-0010-5
Superko HR. Hypercholesterolemia and Dyslipidemia. Curr Treat Options Cardiovasc Med. 2000 Apr;2(2):173-187. doi: 10.1007/s11936-000-0010-5. PMID: 11096522.
Copy Download .nbib Format: NLM
Dyslipidemia in patients with thyroid disorders.

Hormones (Athens, Greece)

Liberopoulos EN, Elisaf MS.
PMID: 17018450
Hormones (Athens). 2002 Oct-Dec;1(4):218-23. doi: 10.14310/horm.2002.1170.

Thyroid disorders are known to influence lipid metabolism and are common in dyslipidemic patients. Overt and subclinical hypothyroidism have an adverse effect on the serum lipid profile that may predispose to the development of atherosclerotic disease. Although thyroid substitution...

Cite
Liberopoulos EN, Elisaf MS. Dyslipidemia in patients with thyroid disorders. Hormones (Athens). 2002;1(4):218-23doi: 10.14310/horm.2002.1170.
Liberopoulos, E. N., & Elisaf, M. S. (2002). Dyslipidemia in patients with thyroid disorders. Hormones (Athens, Greece), 1(4), 218-23. https://doi.org/10.14310/horm.2002.1170
Liberopoulos, Evagelos N, and Elisaf, Moses S. "Dyslipidemia in patients with thyroid disorders." Hormones (Athens, Greece) vol. 1,4 (2002): 218-23. doi: https://doi.org/10.14310/horm.2002.1170
Liberopoulos EN, Elisaf MS. Dyslipidemia in patients with thyroid disorders. Hormones (Athens). 2002 Oct-Dec;1(4):218-23. doi: 10.14310/horm.2002.1170. PMID: 17018450.
Copy Download .nbib Format: NLM
Association of Early Atherosclerotic Vascular Changes with Serum Lipoprotein (a) in Predialysis Chronic Renal Failure and Maintenance Hemodialysis Patients.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia

Nasri H, Baradaran A.
PMID: 18202491
Saudi J Kidney Dis Transpl. 2005 Apr-Jun;16(2):154-60.

Elevated plasma lipoprotein (LPa) level in chronic renal failure patients is recognized as an independent risk factor for premature atherosclerotic coronary heart disease. In this cross-sectional study we aimed to study the effect of serum plasma LPa levels on...

Cite
Nasri H, Baradaran A. Association of Early Atherosclerotic Vascular Changes with Serum Lipoprotein (a) in Predialysis Chronic Renal Failure and Maintenance Hemodialysis Patients. Saudi J Kidney Dis Transpl. 2005;16(2):154-60
Nasri, H., & Baradaran, A. (2005). Association of Early Atherosclerotic Vascular Changes with Serum Lipoprotein (a) in Predialysis Chronic Renal Failure and Maintenance Hemodialysis Patients. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 16(2), 154-60.
Nasri, Hamid, and Baradaran, Azar. "Association of Early Atherosclerotic Vascular Changes with Serum Lipoprotein (a) in Predialysis Chronic Renal Failure and Maintenance Hemodialysis Patients." Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia vol. 16,2 (2005): 154-60.
Nasri H, Baradaran A. Association of Early Atherosclerotic Vascular Changes with Serum Lipoprotein (a) in Predialysis Chronic Renal Failure and Maintenance Hemodialysis Patients. Saudi J Kidney Dis Transpl. 2005 Apr-Jun;16(2):154-60. PMID: 18202491.
Copy Download .nbib Format: NLM
WITHDRAWN: Combination of plant sterols and diacylglycerol oil lowers serum cholesterol and lipoprotein (a) concentrations in postmenopausal women with mild-to-moderate hypercholesterolemia.

Clinical nutrition (Edinburgh, Scotland)

Takeshita M, Saito S, Katsuragi Y, Yasunaga K, Matsuo N, Tokimitsu I, Yasukawa T, Nakamura H.
PMID: 17208337
Clin Nutr. 2007 Jan 08; doi: 10.1016/j.clnu.2006.11.004. Epub 2007 Jan 08.

This article has been withdrawn consistent with Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy). The Publisher apologizes for any inconvenience this may cause.

Cite
Takeshita M, Saito S, Katsuragi Y, et al. WITHDRAWN: Combination of plant sterols and diacylglycerol oil lowers serum cholesterol and lipoprotein (a) concentrations in postmenopausal women with mild-to-moderate hypercholesterolemia. Clin Nutr. 2007;doi: 10.1016/j.clnu.2006.11.004.
Takeshita, M., Saito, S., Katsuragi, Y., Yasunaga, K., Matsuo, N., Tokimitsu, I., Yasukawa, T., & Nakamura, H. (2007). WITHDRAWN: Combination of plant sterols and diacylglycerol oil lowers serum cholesterol and lipoprotein (a) concentrations in postmenopausal women with mild-to-moderate hypercholesterolemia. Clinical nutrition (Edinburgh, Scotland), . https://doi.org/10.1016/j.clnu.2006.11.004
Takeshita, Masao, et al. "WITHDRAWN: Combination of plant sterols and diacylglycerol oil lowers serum cholesterol and lipoprotein (a) concentrations in postmenopausal women with mild-to-moderate hypercholesterolemia." Clinical nutrition (Edinburgh, Scotland) vol. (2007). doi: https://doi.org/10.1016/j.clnu.2006.11.004
Takeshita M, Saito S, Katsuragi Y, Yasunaga K, Matsuo N, Tokimitsu I, Yasukawa T, Nakamura H. WITHDRAWN: Combination of plant sterols and diacylglycerol oil lowers serum cholesterol and lipoprotein (a) concentrations in postmenopausal women with mild-to-moderate hypercholesterolemia. Clin Nutr. 2007 Jan 08; doi: 10.1016/j.clnu.2006.11.004. Epub 2007 Jan 08. PMID: 17208337.
Copy Download .nbib Format: NLM
Double Beta-Lipoprotein: A New Genetic Variant in Man.

Science (New York, N.Y.)

Seegers W, Hirschhorn K, Burnett L, Robson E, Harris H.
PMID: 17838103
Science. 1965 Jul 16;149(3681):303-4. doi: 10.1126/science.149.3681.303.

A beta-lipoprotein variant, in which two bands appear after electrophoresis, has been found in three generations of a family. The variant, immunologically also a beta-lipoprotein, differs in molecular size, density, and charge fromn normal beta-lipoprotein. Individuals showing the variant...

Cite
Seegers W, Hirschhorn K, Burnett L, et al. Double Beta-Lipoprotein: A New Genetic Variant in Man. Science. 1965;149(3681):303-4doi: 10.1126/science.149.3681.303.
Seegers, W., Hirschhorn, K., Burnett, L., Robson, E., & Harris, H. (1965). Double Beta-Lipoprotein: A New Genetic Variant in Man. Science (New York, N.Y.), 149(3681), 303-4. https://doi.org/10.1126/science.149.3681.303
Seegers, W, et al. "Double Beta-Lipoprotein: A New Genetic Variant in Man." Science (New York, N.Y.) vol. 149,3681 (1965): 303-4. doi: https://doi.org/10.1126/science.149.3681.303
Seegers W, Hirschhorn K, Burnett L, Robson E, Harris H. Double Beta-Lipoprotein: A New Genetic Variant in Man. Science. 1965 Jul 16;149(3681):303-4. doi: 10.1126/science.149.3681.303. PMID: 17838103.
Copy Download .nbib Format: NLM
Application of protein lysate microarrays to molecular marker verification and quantification.

Proteome science

Ramaswamy A, Lin E, Chen I, Mitra R, Morrisett J, Coombes K, Ju Z, Kapoor M.
PMID: 16281978
Proteome Sci. 2005 Nov 10;3:9. doi: 10.1186/1477-5956-3-9.

This study presents the development and application of protein lysate microarray (LMA) technology for verification of presence and quantification of human tissue samples for protein biomarkers. Sub-picogram range sensitivity has been achieved on LMA using a non-enzymatic protein detection...

Cite
Ramaswamy A, Lin E, Chen I, et al. Application of protein lysate microarrays to molecular marker verification and quantification. Proteome Sci. 2005;3:9doi: 10.1186/1477-5956-3-9.
Ramaswamy, A., Lin, E., Chen, I., Mitra, R., Morrisett, J., Coombes, K., Ju, Z., & Kapoor, M. (2005). Application of protein lysate microarrays to molecular marker verification and quantification. Proteome science, 39. https://doi.org/10.1186/1477-5956-3-9
Ramaswamy, Anitha, et al. "Application of protein lysate microarrays to molecular marker verification and quantification." Proteome science vol. 3 (2005): 9. doi: https://doi.org/10.1186/1477-5956-3-9
Ramaswamy A, Lin E, Chen I, Mitra R, Morrisett J, Coombes K, Ju Z, Kapoor M. Application of protein lysate microarrays to molecular marker verification and quantification. Proteome Sci. 2005 Nov 10;3:9. doi: 10.1186/1477-5956-3-9. PMID: 16281978; PMCID: PMC1334216.
Copy Download .nbib Format: NLM
Metabolic aspects of trans fatty acids.

Clinical nutrition (Edinburgh, Scotland)

Koletzko B, Decsi T.
PMID: 16844601
Clin Nutr. 1997 Oct;16(5):229-37. doi: 10.1016/s0261-5614(97)80034-9.

The consumption of trans isomers of unsaturated fatty acids has been associated withuntoward metabolic effects. Several clinical investigations demonstrated that trans fatty acids increase plasma LDL-cholesterol and lipoprotein (a) and reduce HDL-cholesterol concentrations. These alterations of plasma lipid profiles...

Cite
Koletzko B, Decsi T. Metabolic aspects of trans fatty acids. Clin Nutr. 1997;16(5):229-37doi: 10.1016/s0261-5614(97)80034-9.
Koletzko, B., & Decsi, T. (1997). Metabolic aspects of trans fatty acids. Clinical nutrition (Edinburgh, Scotland), 16(5), 229-37. https://doi.org/10.1016/s0261-5614(97)80034-9
Koletzko, B, and Decsi, T. "Metabolic aspects of trans fatty acids." Clinical nutrition (Edinburgh, Scotland) vol. 16,5 (1997): 229-37. doi: https://doi.org/10.1016/s0261-5614(97)80034-9
Koletzko B, Decsi T. Metabolic aspects of trans fatty acids. Clin Nutr. 1997 Oct;16(5):229-37. doi: 10.1016/s0261-5614(97)80034-9. PMID: 16844601.
Copy Download .nbib Format: NLM
Effects of rice policosanol on serum lipoproteins, homocysteine, fibrinogen and C-reactive protein in hypercholesterolaemic patients.

Clinical drug investigation

Reiner Z, Tedeschi-Reiner E, Romić Z.
PMID: 17532716
Clin Drug Investig. 2005;25(11):701-7. doi: 10.2165/00044011-200525110-00003.

BACKGROUND: Policosanol is an agent that includes mixtures of aliphatic primary alcohols extracted primarily from sugar-cane wax. This mixture has been shown to lower total and low-density lipoprotein (LDL) cholesterol in animal models, healthy volunteers and hypercholesterolaemic patients.PATIENTS AND...

Cite
Reiner Z, Tedeschi-Reiner E, Romić Z. Effects of rice policosanol on serum lipoproteins, homocysteine, fibrinogen and C-reactive protein in hypercholesterolaemic patients. Clin Drug Investig. 2005;25(11):701-7doi: 10.2165/00044011-200525110-00003.
Reiner, Z., Tedeschi-Reiner, E., & Romić, Z. (2005). Effects of rice policosanol on serum lipoproteins, homocysteine, fibrinogen and C-reactive protein in hypercholesterolaemic patients. Clinical drug investigation, 25(11), 701-7. https://doi.org/10.2165/00044011-200525110-00003
Reiner, Zeljko, et al. "Effects of rice policosanol on serum lipoproteins, homocysteine, fibrinogen and C-reactive protein in hypercholesterolaemic patients." Clinical drug investigation vol. 25,11 (2005): 701-7. doi: https://doi.org/10.2165/00044011-200525110-00003
Reiner Z, Tedeschi-Reiner E, Romić Z. Effects of rice policosanol on serum lipoproteins, homocysteine, fibrinogen and C-reactive protein in hypercholesterolaemic patients. Clin Drug Investig. 2005;25(11):701-7. doi: 10.2165/00044011-200525110-00003. PMID: 17532716.
Copy Download .nbib Format: NLM
Antiphospholipid antibodies and lipoprotein (a) as etiologic or contributory factors in patients with idiopathic cavernous transformation of portal vein.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology

Egesel T, Unsal I, Bayraktar Y.
PMID: 16378283
Turk J Gastroenterol. 2002 Jun;13(2):89-93.

BACKGROUND/AIMS: Antiphospholipid antibodies consisting of anticardiolipin antibodies and lupus anticoagulant are strongly associated with thrombosis in adult patients. It is also well known that there is a close relationship between antiphospholipid antibodies and lipoprotein (a) in thrombous formation. The...

Cite
Egesel T, Unsal I, Bayraktar Y. Antiphospholipid antibodies and lipoprotein (a) as etiologic or contributory factors in patients with idiopathic cavernous transformation of portal vein. Turk J Gastroenterol. 2002;13(2):89-93
Egesel, T., Unsal, I., & Bayraktar, Y. (2002). Antiphospholipid antibodies and lipoprotein (a) as etiologic or contributory factors in patients with idiopathic cavernous transformation of portal vein. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 13(2), 89-93.
Egesel, Türker, et al. "Antiphospholipid antibodies and lipoprotein (a) as etiologic or contributory factors in patients with idiopathic cavernous transformation of portal vein." The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology vol. 13,2 (2002): 89-93.
Egesel T, Unsal I, Bayraktar Y. Antiphospholipid antibodies and lipoprotein (a) as etiologic or contributory factors in patients with idiopathic cavernous transformation of portal vein. Turk J Gastroenterol. 2002 Jun;13(2):89-93. PMID: 16378283.
Copy Download .nbib Format: NLM
Is lipoprotein(a) a clinically meaningful risk marker for cardiovascular events in healthy women?.

Nature clinical practice. Cardiovascular medicine

Fruchart JC.
PMID: 17356519
Nat Clin Pract Cardiovasc Med. 2007 May;4(5):242-3. doi: 10.1038/ncpcardio0851. Epub 2007 Mar 13.

No abstract available.

Cite
Fruchart JC. Is lipoprotein(a) a clinically meaningful risk marker for cardiovascular events in healthy women?. Nat Clin Pract Cardiovasc Med. 2007;4(5):242-3doi: 10.1038/ncpcardio0851.
Fruchart, J. C. (2007). Is lipoprotein(a) a clinically meaningful risk marker for cardiovascular events in healthy women?. Nature clinical practice. Cardiovascular medicine, 4(5), 242-3. https://doi.org/10.1038/ncpcardio0851
Fruchart, Jean-Charles. "Is lipoprotein(a) a clinically meaningful risk marker for cardiovascular events in healthy women?." Nature clinical practice. Cardiovascular medicine vol. 4,5 (2007): 242-3. doi: https://doi.org/10.1038/ncpcardio0851
Fruchart JC. Is lipoprotein(a) a clinically meaningful risk marker for cardiovascular events in healthy women?. Nat Clin Pract Cardiovasc Med. 2007 May;4(5):242-3. doi: 10.1038/ncpcardio0851. Epub 2007 Mar 13. PMID: 17356519.
Copy Download .nbib Format: NLM
Dyslipidaemia in Adult Growth Hormone (GH) Deficiency and the Effect of GH Replacement Therapy: A Review.

Trends in endocrinology and metabolism: TEM

Christ ER, Cummings MH, Russell-Jones DL.
PMID: 18406266
Trends Endocrinol Metab. 1998 Jul;9(5):200-6. doi: 10.1016/s1043-2760(98)00050-2.

Adult growth hormone (GH) deficiency is associated with a lipid profile known to be related to atherosclerosis. GH replacement therapy improves the lipid profile with the exception of lipoprotein (a) concentrations, which tend to increase after GH therapy. Plasma...

Cite
Christ ER, Cummings MH, Russell-Jones DL. Dyslipidaemia in Adult Growth Hormone (GH) Deficiency and the Effect of GH Replacement Therapy: A Review. Trends Endocrinol Metab. 1998;9(5):200-6doi: 10.1016/s1043-2760(98)00050-2.
Christ, E. R., Cummings, M. H., & Russell-Jones, D. L. (1998). Dyslipidaemia in Adult Growth Hormone (GH) Deficiency and the Effect of GH Replacement Therapy: A Review. Trends in endocrinology and metabolism: TEM, 9(5), 200-6. https://doi.org/10.1016/s1043-2760(98)00050-2
Christ, E R, et al. "Dyslipidaemia in Adult Growth Hormone (GH) Deficiency and the Effect of GH Replacement Therapy: A Review." Trends in endocrinology and metabolism: TEM vol. 9,5 (1998): 200-6. doi: https://doi.org/10.1016/s1043-2760(98)00050-2
Christ ER, Cummings MH, Russell-Jones DL. Dyslipidaemia in Adult Growth Hormone (GH) Deficiency and the Effect of GH Replacement Therapy: A Review. Trends Endocrinol Metab. 1998 Jul;9(5):200-6. doi: 10.1016/s1043-2760(98)00050-2. PMID: 18406266.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 682 entries